in Mailand (Italien)

Dr. Paolo Casale is the Urology Unit Director in Humanitas Research Hospital. 

Medical areas of interest: 
his main focus is surgical treatment of oncological and functional diseases of the kidney, bladder and prostate.

He has developed a particular interest in conservative oncological surgery of the kidneys, both traditional and minimally invasive (laparoscopic and robotic), and has dedicated himself to the study of prostate and bladder oncological pathologies, with particular attention to the different urinary derivations, such as orthotopic neobladders.

Research areas of interest:
Surgical techniques in the treatment of kidney, bladder and prostate cancer.

Previous experience:

• 1999 – 2014 University Hospital of Pisa – Pisa (PI), Italy
  Medical Director at the Urology Unit 2 (Reference Center for Kidney tumors) headed by Dr. Francesco Francesca. Here he served as the organization and surgical training manager in the operating room of Residents in Urology and Students of Degree in Medicine and Surgery.
• He has also held the following positions: 
•  
• May 2012 – May 2013: Head of the Section of Professional interdisciplinary relevance of Robot-assisted Laparoscopic Surgery 
•  
• Nov 2008 – April 2012: Head of the Robot assisted Laparoscopic Surgery
•  
• 1994 – 2004: Research Fellow in Laparoscopic Surgery and Robotics at the Glickman Urological Institute at The Cleveland Clinic Foundation on advanced laparoscopic procedures, Robotic Surgery and Minimally Invasive Surgery – Cleveland – USA. (Chief: IS Gill).
•  
• December 1995 – May 1996: Research Fellow at the Department of Urology, Henry Ford Hospital – Detroit – Michigan – USA. (Chief: JO Peabody).
•  
• 1994: Clinical Internship at the Department of Urology, Montefiore Medical Center – Albert Einstein ​​University – New York – USA. (Chief: A. Mellman).

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=casale p 

Dott. Antonio Frontera is the Electrophysiology Unit Director in Humanitas Research Hospital.  

Medical areas of interest: 

After graduating in Medicine and Surgery at the University Cattolica del Sacro Cuore in Rome in 2006, he specialized in Cardiology at the same university in 2012.

Soon after his specialization he moved to England where he was hired as a Clinical and Research Fellow in cardiac electrophysiology at the Bristol Heart Institute (NHS), Bristol. 
He won a scholarship from the European Society of Aritmology (EHRA) and completed his training in cardiac electrophysiology at the prestigious Haut Léveque Hospital in Bordeaux, France, directed by Prof. Michel Haïssaguerre. In the same French university, he obtained his PhD.

During these 5 years of training abroad, he performed about 800 trans catheter ablation surgeries focusing mainly on the treatment of supraventricular arrhythmias. As a researcher, he has published nearly 100 scientific papers on innovation and trans catheter ablation techniques, defibrillator and pacemaker functioning algorithms.

Back to Italy, he was employed at the Aritmology Unit of the San Raffale Hospital specializing in the treatment of ventricular tachycardia, performing more than 150 procedures as a first and second operator.

To date, Dr. Frontera is the author of more than 145 scientific papers published in international journals. He constantly participates in national and international congresses of the sector.

Research areas of interest:
He has particular interest in the analysis of endocavitary signals (EGMs) in ventricular tachycardia and atrial fibrillation.

Thanks to a close collaboration with the Mathematics department of Politecnico di Milano, directed by Prof. Quarteroni, he studied innovative techniques for the treatment of complex arrhythmias.

Previous experience:
 

• Clinical and Research Fellow in Cardiac Electrophysiology - Bristol Heart Institute, Bristol, UK
• Clinical and Research Fellow in Cardiac Electrophysiology - Hôpital Haut Léveque, Bordeaux, FR

Publications: 

Sinus node exit, crista terminalis conduction, interatrial connection and wavefront collision: key features of human atrial activation in sinus rhythm.
Pambrun T, Derval N, Duchateau J, Ramirez FD, Chauvel R, Tixier R, Marchand H, Bouyer B, Welte N, André C, Nakashima T, Nakatani Y, Kamakura T, Takagi T, Krisai P, Ascione C, Balbo C, Cheniti G, Vlachos K, Bourier F, Takigawa M, Kitamura T, Frontera A, Meo M, Denis A, Sacher F, Hocini M, Jaïs P, Haïssaguerre M.Heart Rhythm. 2022 Jan 13

Electrogram fractionation during sinus rhythm occurs in normal voltage atrial tissue in patients with atrial fibrillation.
Frontera A, Limite LR, Pagani S, Cireddu M, Vlachos K, Martin C, Takigawa M, Kitamura T, Bourier F, Cheniti G, Pambrun T, Sacher F, Derval N, Hocini M, Quarteroni A, Della Bella P, Haissaguerre M, Jaïs P.Pacing Clin Electrophysiol. 2021

Slow Conduction Corridors and Pivot Sites Characterize the Electrical Remodeling in Atrial Fibrillation - ScienceDirect
Antonio Frontera MD, Ph.D1, Stefano Pagani Ph.D2, Luca Rosario Limite MD1, Andrea Peirone MD1, Francesco Fioravanti MD1, Bogdan Enache MD6, Jose Cuellar, MD4, Konstantinos Vlachos, MD5, Christian Meyer, MD, MA7, Giovanni Montesano, MD8, Andrea Manzoni, Ph.D2, Luca Dedè2 Ph.D2, Alfio Quarteroni, Ph.D2,3, Decebal Gabriel Lațcu, MD6, Pietro Rossi MD, Ph.D9, Paolo Della Bella MD1.
JACC EP Jan 2022

Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and high-risk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool?
Letsas KP, Vlachos K, Conte G, Efremidis M, Nakashima T, Duchateau J, Bazoukis G, Frontera A, Mililis P, Tse G, Cheniti G, Takigawa M, Pambrun T, Prappa E, Sacher F, Derval N, Sideris A, Auricchio A, Jais P, Haissaguerre M, Hocini M.J Cardiovasc Electrophysiol. 2021

Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterization.
Takigawa M, Kitamura T, Basu S, Bartal M, Martin CA, Martin R, Cheniti G, Vlachos K, Pillois X, Frontera A, Massoullié G, Thompson N, Bourier F, Lam A, Duchateau J, Pambrun T, Denis A, Derval N, Cochet H, Haïssaguerre M, Sacher F, Hocini M, Jaïs P.Heart Rhythm. 2022 Jan;

Prof. Bruno Bernardini is the Neurological Rehabilitation Unit Director in Humanitas Research Hospital. 

Medical areas of interest:

Rehabilitation in acute-subacute phase of disabled patients for neurological diseases (stroke, cranial-encephalic and medullary trauma, tumors of the nervous system, neuropathies). Hospital risk of fragile elderly patients. Orthogeriatrics.

Research areas of interest:
Post-operative rehabilitation indicators and process-outcome measures for patient prognostic stratification and clinical performance evaluation. 

He is the coordinator of a multicentre study for the application of process-outcome indicators in rehabilitation. The study involves hospital and extra-hospital facilities in Lombardy, Liguria and other regions of Central and Northern Italy.

Previous experience:

2005-2007 Galliera Hospital Authority, Genoa, Italy

Director of the Functional Recovery structure.

Member of the work group for defining the Regional Plan of rehabilitation work 2006-2009 in the Liguria region.

Evaluation, treatment and facilitation of care processes in patients in Neurology, Intensive Care, Neuro-surgery, Intermediate Care, Orthopaedic and Home Care. 

Outpatient work as a physiatric specialist, with a specific sector on the rehabilitation of the pelvic floor.

Development of processes in diagnostic and therapeutic hospital care (especially lumbar-sciatica, joint replacements, cardiac failure, femur fractures and most fast-track urological operations).

1988-1995 Hospital of Niguarda, Milan, Italy
Visiting doctor at the Centre for High Specialisation in Allergology and Clinical Immunology with full-time specialisation in the Department of Pneumology Piazza.

Teaching experience: Medicine Professor at the University of Genoa.

Scientific activities: Member of the board of directors and Geriatric area contact person at “Italian Urodynamic Society Continence, Neuro-Urology, Pelvic Floor”

Prof. Arturo Chiti graduated in Medicine and Surgery at the University of Milan in 1989, and in the same year he entered the Post graduated School in Nuclear Medicine at the University of Milan, where he got his degree in 1993. In the same year he started working as Associate Chief at the National Cancer Institute in Milan, where he began his clinic and scientific experience in Oncology.
In 1997, he got the European Board of Nuclear Medicine fellowship.

In June 2000 he started leading the Nuclear Medicine Department at Humanitas Research Hospital.

On March 1, 2015 he was appointed Full Professor in Diagnostic Imaging and Radiotherapy at the Humanitas University in Milan, where he is also elected member of the Board.

Prof. Chiti is the Unit Director of the Nuclear Medicine Unit in Humanitas Research Hospital. He is the Director of the Post Graduate School in Diagnostic Imaging at Humanitas University. He is member of the Technical and Scientific Committee of the National Centre for Oncologic Adrotherapy (CNAO).

Arturo Chiti is co-author of several papers (www.scopus.com, www.pubmed.com) with an H-index of 30 (July 2016), wrote some books’ chapters and contributed to many abstracts presented at international and national meetings.
He is Honorary Editor of the European Journal of Nuclear Medicine and Molecular Imaging and reviewer for several international journals and grant applications.

He is a well-known invited speaker at numerous international congresses and conferences.

Prof. Arturo Chiti is the President of the European Association of Nuclear Medicine (EANM), where he has been active for more than 10 years.

He is also acting as an expert consultant for International Atomic Energy Agency (IAEA) and is member of the International Commission on Radiation Units and Measurements (ICRU).

He was awarded the honorary membership of the European Society for Therapeutic Radiology and Oncology (ESTRO); the Tom Miller Memorial Lecture Award from the Society of Nuclear Medicine and Molecular Imaging and the Hevesy Gyorgy award from the Hungarian Society of Nuclear Medicine.

Publications:

https://www.ncbi.nlm.nih.gov/pubmed/?term=chiti+arturo

Prof. Antonio Costanzo is the Dermatology Unit Director in Humanitas Research Hospital. He graduated with his MD degree in Medicine and Surgery from the University of Rome, La Sapienza in 1994. He then went on to complete post-graduate study and received a speciality degree in Internal Medicine in 1999 and a Dermatology speciality degree in 2006.

Medical areas of interest:

• Inflammatory and autoimmune skin diseases (Psoriasis, Atopic Dermatitis, Alopecia Areata, Chronic Urticaria, Suppurative Hydroadenitis, Scleroderma, Lupus)
• Personalized Medicine, Biological Psoriasis Therapy
• Dermatological Oncology (Melanoma, Actinic Keratosis, Basocellular and Spinocellular Epitheliomas).
• Prevention of skin neoplasms (dermatoscopy, computer mapping of moles).
• Dermatological surgery

Previous experience:

• Director of Dermatology Unit at Sant’Andrea Hospital in Vercelli
• University Researcher/Hospital Assistant at Tor Vergata Hospital 

Research areas of interest: 

• Psoriasis pathogenesis of other inflammatory and autoimmune skin diseases
• Pathogenesis of skin neoplasms
• Genetic disorders of the skin

His clinical research is focused on the characterization of the activity of biologics in psoriasis and psoriatic arthritis. This research is strictly linked to basic research activity on the pathogenesis of psoriasis and on the use of pharmacogenetic approach to predict the efficacy and safety of biologics in psoriasis.

In the past, Professor Costanzo has collaborated to the characterization of basic mechanisms of TNF inflammatory signalling in epithelial cells and NFkappaB regulation by different stimuli. More recently his research group has collaborated to the discovery of IL-21 as critical mediator of keratinocyte proliferation in psoriasis. Professor Costanzo has authored or co-authored more than 120 publications in internationally peer-reviewed journals.

Teaching experience: Full Professor of Dermatology at Humanitas University

Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Costanzo+A 

Dr. Marco Grimaldi is the Diagnostic Neuroradiology Unit Director in Humanitas Research Hospital.

Medical areas of interest:

• magnetic resonance
• computed tomography
• angiography of the central nervous system, brain and spine
• study of the brachial plexus
• functional neuroradiology, in particular, study of cerebral perfusion for perfusion CT related to problems in an emergency regime
• spine dimorphism, in particular of the paediatric age and in rare diseases

He has developed full diagnostic, organizational and managerial autonomy of any problem in outpatient, hospital and emergency neuroradiology.

Research areas of interest:

• Functional imaging studies on coma
• Diagnosis and development of prognostic algorithms
• Research and development, even experimental, of new applications related to technological developments (research on new protocols for the use of the Multidetector Computed Tomography (MDCT), for the use of perfusion CT in vascular and emergency environments finally, study of the trachea in patients at risk of anesthesiology).

Previous experience:

1990 – 2012 Neuroradiologist at Hospital of San Gerardo in Monza, Italy

He was the Director on highly specialised activities related to functional neuroradiology. 

He worked in diagnostic autonomy, organization and management of any problem within neuroradiological outpatient, inpatient and emergency context. 

He is particularly interested in the field of functional neuroradiology, in research and experimental development of new applications also tied to technological developments and creation of new protocols for use of MDCT (use of CT perfusion imaging in the field of vascular and urgency. He was involved in the study of the trachea in patients at high anaesthetic risk), in paediatric radiology with particular reference to diagnosis and clinical management of rare diseases (consultant in the Outpatient Unit for metabolic diseases and in the Outpatient Unit for rare and genetic diseases at the Hospital). He is also interested in the study of problems related to the craniocervical junction.

Teaching experience: 

From 2002 to 2012 he has been a professor at Milano-Bicocca University of Milan.

From 2002 to 2012 : Professor of the courses "Technique and diagnostics for images I", "Technique and diagnostics for images II" and "Semeiotics neuroradiological CT" for the degree in Medical Radiology for Images and Radiotherapy.
From 2003 to 2012: Professor of the course "Functional Brain Diagnostics" for the Degree in Physiotherapy. 
From 2003 to 2012: Professor for the Degree Course in Neurotherapy and psychomotricity of the developmental age.
From 2006 to 2009: Lecturer at the School of Specialization in Radiodiagnostics.

Prof. Marco Alloisio is the thoracic surgery Unit Director at Humanitas Research Hospital. He graduated in Medicine in 1976 at Università Statale of Milan, specialized in General Surgery, Oncological and Thoracic Surgery. 

Under the guidance of Professor Umberto Veronesi, from 1977 to 1997 he was an assistant in the divisions of general oncological, otolaryngology and thoracic surgery at the National Cancer Institute of Milan (INT). During this period, he also worked with general surgery, breast surgery, oncological otorhinolaryngology and had several periods spent studying abroad (Paris and New York at the Memorial Sloan Kettering Cancer Center).

In 1997 he started his activity at Humanitas Research Hospital and in 1998 he was appointed Chief of Mini-Invasive Thoracic Surgery. From 2006 he was designated Chief of Thoracic Surgery at the same Institution. Main clinical activity has been focused on Thoracic Surgical Oncology, and in particular all kinds of surgical management of primary and secondary lung cancer, lung metastases, mediastinal tumors and thoracic wall tumors. Prof. Marco Alloisio is president of the Italian League for the fight against cancer (LILT) in Milan, and member of many national and international societies (SIC, SICO, ESSO, ISDE, ACOI, SICT, ESTS).

Author of over 200 publications, including articles and presentations to national and internationals scientific meetings. His engagement in clinical research involves early detection and management of primary lung cancer and his treatment also with video-assisted techniques, successful treatment of lung metastases with new techniques for salvage surgery (multiple sub lobar resections and laser resections) but also aggressive surgery for advanced lung cancers after induction chemotherapy and treatment of the thoracic wall and vertebral bodies. 
In the latter field, he is engaged in the surgical treatment of malignant pleural mesothelioma (extra pleural pneumonectomy) with multimodality approaches in a multicentric Italian cooperative group.

Currently engaged in genetic research studies such as "ERCC1 and B-Tubulin exspression in locally advanced NSCLC treated with platinum/vinorelbin neodjuvant chemotherapy" and in external collaborations with universities and hospitals around the world.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=alloisio+marco

Dr. Lorenzo Di Mento is the Head of the Traumatology Unit in Humanitas Research Hospital. He is also part of the council of AO Trauma Italy with the role of Community Development. 

He specialized in Orthopaedics and Traumatology at the University of Milan (2000-2005), completing several internships abroad:

• 2003 Marseille (France), Centre Phocea, Dr. Bronsard, vertebral surgery
• 2003 Marseille (France), Hopital Nord, Dr. Poitout, traumatology
• 2003-2004 Basse Terre (Guadeloupe), Centro Ospedaliero de la Basse Terre (CHBT), dr Fleurat, acting as intern (equivalent of the French specializing)

He also completed a Fellowship of AO Trauma International at the Centre Hospitalier Universitaire Vadois (CHUV) in Lausanne (Switzerland) in 2016, at the center of pelvic surgery and treatment of septic complications in orthopedics and traumatology, directed by Dr. Borens.

He surgically treats fractures, both acutely ongoing ones (with intervention of reduction and synthesis as soon as possible, in accordance with soft tissues and the patient’s conditions) and as psthumous traumas (pseudoarthrosis, bad or non consolidation). He handles polyfractured and polytrauma patients. Dr. Di Mento also treats infections in a traumatic environment, such as septic psedutoarthrosis and surgically the minor tumoral bone localizations, such as osteolysis, impending fractures and pathological fractures. 

Publications: https://pubmed.ncbi.nlm.nih.gov/?term=Di+Mento+L 

Dott. Federico Della Rocca is the Prosthetic and Minimally Invasive Hip and Knee Orthopaedics. 

Medical areas of interest: 
Pathology of the hip and knee, with particular interest in prosthetic and arthroscopic hip surgery. He performs about 700 surgeries every year. He has numerous participations as speaker at national and international conferences.

Previous experience:
He was an attending physician at Steadman Hawkins Clinic Hospital, Vail Colorado, USA. 

He gave a great contribution to the development of the GTS (Global Tissue Sparing) hip prosthetic stem and biomechanical rotational stability tests with Prof Thomsen, Heidelberg (Germany) 12/2012.

Research areas of interest: 
Arthroscopic techniques on the hip

Teaching experience: 
Theory and practical courses in arthroscopic and prosthetic hip surgery at Medical Education

Dr. Giuseppe Curigliano ist Leiter der Abteilung für frühe Arzneimittelentwicklung am Europäischen Institut für Onkologie und außerordentlicher Professor für medizinische Onkologie an der Universität Mailand in Italien. Er ist Gründungsmitglied und wissenschaftlicher Vorsitzender der International Cardio-Oncology Society (ICOS) und hat 2017 den ersten ESO Umberto Veronesi Award in Wien und 2017 das Fellowship der European Academy of Cancer Sciences in Paris erhalten.

Nicoletta Colombo ist Direktorin am Ovarian Cancer Center am IEO, Autorin zahlreicher Publikationen auf dem Gebiet der gynäkologischen Onkologie und Mitglied von ASCO, SGO und IGCS.

Dr. Mohssen Ansarin ist Onkologe mit Spezialisierung auf Kopf-Hals-Krebs und Fördermitglied von SRS und AIOCC. Er ist Autor und Co-Autor von mehr als 50 Artikeln und derzeit Chefredakteur von ACTA Otolaryngologica.

Der Direktor der Doctor's Equipe Clinic. Der Erfinder des Microfat-Systems. Spezialist für Kiefer- und Gesichtschirurgie und ästhetisch-kosmetische Korrekturen.

Onkologe-Urologe

Chirurg, Senologe

Barbara Alicia Erechek ist Direktorin der Abteilung für Strahlentherapie am Europäischen Krebszentrum in Mailand und Professorin für Radioonkologie an der Universität Mailand. Der Arzt ist spezialisiert auf Strahlentherapie bei allen Arten von Krebs und metastasierenden Tumoren.

• 26 Jahre Erfahrung in Strahlentherapie;
• 140 wissenschaftliche Publikationen.

Professor Erechek erhielt 1992 ihren medizinischen Abschluss an der Universität Danzig (Polen). Ihre Qualifikationen auf dem Gebiet der Radioonkologie verbesserte sie am Onkologischen Institut Warschau, der Universität Mailand, dem Beatson Cancer Center der Universität Glasgow (UK). Seit 1997 arbeitet der Mediziner als Facharzt für Strahlentherapie am Europäischen Krebszentrum. Seit 2015 leitet sie die Abteilung Strahlentherapie der Klinik.

Arzttermin

Ein Termin bei Dr. Erechek zur Bestrahlungsplanung dauert 30-50 Minuten. Der Arzt untersucht die Krankenakten und Testergebnisse des Patienten. Sie erklärt die Diagnose, spricht über die weitere Behandlung. Der Arzt gibt Empfehlungen, wie man sich am besten auf den Ablauf der Eingriffe vorbereitet, damit sie am angenehmsten sind.

Um eine Beratung von Professor Erechek zu erhalten, hinterlassen Sie eine Anfrage auf der Bookimed-Website. Der medizinische Koordinator wird sich mit Ihnen in Verbindung setzen, um das Datum und die Uhrzeit der Konsultation zu vereinbaren.

Wissenschaftliche Tätigkeit

Professorin Barbara Alicia Erechek ist Autorin von 140 wissenschaftlichen Publikationen.

Berufliche Erfolge und Auszeichnungen

Zwischen 1999 und 2003 erhielt Prof. Jereczek 4 Auszeichnungen von der Medizinischen Universität Danzig für Forschung auf dem Gebiet der Onkologie und Strahlentherapie.

Mitgliedschaft in Organisationen

• ESTRO - Europäische Gesellschaft für Therapeutische Radiologie und Onkologie;
• AIRO – Italienische Gesellschaft für Radioonkologie;
• European Oncology Institute New Protocol Review Committee, Mailand, Italien;
• Qualitätsausschuss für klinische Studien des Europäischen Instituts für Onkologie, Mailand, Italien.